BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31399787)

  • 21. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clear Cell Renal Cell Carcinoma: Associations Between CT Features and Patient Survival.
    Hötker AM; Karlo CA; Zheng J; Moskowitz CS; Russo P; Hricak H; Akin O
    AJR Am J Roentgenol; 2016 May; 206(5):1023-30. PubMed ID: 26934514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
    Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
    Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
    Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of low- and high-grade clear cell renal cell carcinoma: Tumor size versus CT perfusion parameters.
    Chen C; Kang Q; Xu B; Guo H; Wei Q; Wang T; Ye H; Wu X
    Clin Imaging; 2017; 46():14-19. PubMed ID: 28686936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma.
    Zhu YH; Wang X; Zhang J; Chen YH; Kong W; Huang YR
    AJR Am J Roentgenol; 2014 Sep; 203(3):W295-300. PubMed ID: 25148187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal-cell carcinoma: additional information for selecting candidates for surveillance protocols.
    Villalobos-Gollás M; Aguilar-Davidov B; Culebro-García C; Gómez-Alvarado MO; Rojas-Garcia P; Ibarra-Fombona R; Uribe-Uribe N; Feria-Bernal G; Castillejos-Molina R; Sotomayor M; Gabilondo F; Rodríguez-Covarrubias F
    Int Urol Nephrol; 2012 Oct; 44(5):1369-74. PubMed ID: 22648292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
    An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
    Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma.
    Song W; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    World J Urol; 2016 Jan; 34(1):83-8. PubMed ID: 25981404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of tumor volume on survival in patients with renal cell carcinoma.
    Seçil M; Çullu N; Aslan G; Mungan U; Uysal F; Tuna B; Yörükoğlu K
    Diagn Interv Radiol; 2012; 18(5):480-7. PubMed ID: 22618630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma.
    Feng Z; Shen Q; Li Y; Hu Z
    Cancer Imaging; 2019 Feb; 19(1):6. PubMed ID: 30728073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
    Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
    BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review.
    Kovac E; Firoozbakhsh F; Zargar H; Fergany A; Elsharkawy H
    Can J Anaesth; 2017 Jul; 64(7):754-762. PubMed ID: 28417354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of radiologic tumor volume and pathologic tumor volume in renal cell carcinoma (RCC).
    Choi SM; Choi DK; Kim TH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    PLoS One; 2015; 10(3):e0122019. PubMed ID: 25799553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
    Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma.
    Kim SH; Park WS; Kim SH; Seo HK; Joung JY; Lee KH; Chung J
    PLoS One; 2017; 12(5):e0177975. PubMed ID: 28562690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.
    Parker WP; Cheville JC; Frank I; Zaid HB; Lohse CM; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2017 Apr; 71(4):665-673. PubMed ID: 27287995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.